Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
about
Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart DiseaseHydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse BrainProgress toward in vivo use of siRNAs-IIMicroporation is a valuable transfection method for gene expression in human adipose tissue-derived stem cellsCationic polyene phospholipids as DNA carriers for ocular gene therapy.Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cellsEngineering endostatin-producing cartilaginous constructs for cartilage repair using nonviral transfection of chondrocyte-seeded and mesenchymal-stem-cell-seeded collagen scaffolds.Use of gene therapy in central nervous system repair.Branched polyethylenimine-grafted-carboxymethyl chitosan copolymer enhances the delivery of pDNA or siRNA in vitro and in vivo.RNA interference as an anticancer therapy: a patent perspective.siRNA: novel therapeutics from functional genomics.Therapeutic potential of siRNA and DNAzymes in cancer.Temporal endogenous gene expression profiles in response to lipid-mediated transfection.Phospholipid-Nucleic Acid Complexation: Biomolecular Energetics of DNA-Mg(2+)-Phosphatidylcholine Ternary Complex Formation, Compaction and Relevance as Lipoplex Formulation.Tripartite polyionic complex (PIC) micelles as non-viral vectors for mesenchymal stem cell siRNA transfection.Cationic amino acid based lipids as effective nonviral gene delivery vectors for primary cultured neurons.Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals.Psychopharmacology of maternal separation anxiety in vervet monkeys.Lack of hypo/hyperglycemic effects of reboxetine in diabetic and non-diabetic rats.Temporal endogenous gene expression profiles in response to polymer-mediated transfection and profile comparison to lipid-mediated transfection.
P2860
Q26770129-318442C2-EF03-4D10-B341-D1147491DCC7Q27317421-0D59E8D1-91FA-4E37-851F-E3853AF8ACF6Q28255877-015E36E3-EC0C-4D5B-BDB0-5A8760A9F904Q33713216-0B8C3FD3-2B56-436C-8251-518BB31734AAQ34039984-E41BC5AB-7B5E-4F5D-9CC6-86FAB6149AB4Q35234713-FA733BB1-E86F-4432-BEE4-800EB34BD7C0Q35290727-66718D5E-8F9B-48D3-A47A-60D6042BBA5AQ35599603-00F6672B-0517-4564-8DD7-BFB12E998F76Q37219130-B59F8928-6E0F-466B-93A4-1E7CB452B814Q37481329-8BA2DD9E-6BEF-4614-A9B9-EA78B0F3531BQ38229425-67CF662B-0D1F-4752-9398-6A2F621952CCQ38242397-F68EA98F-E6C3-4ABD-9494-90E71985BAFFQ38467034-25C20EF4-BA3F-4D28-B0C2-C9359138C0B5Q39525565-78121A84-6EE5-4B50-9306-E04700C36123Q40117268-C5A7A6CF-D341-485C-A195-C71D54468742Q41992359-FACC130B-00E9-49D3-A53B-CC2F52F6B227Q42259491-CB527982-A4D3-427C-A8D8-D2DDE1B46B99Q46729717-B3A3F20C-4A3D-4AE0-B9FD-D523B8D38B7FQ46824195-CDADA620-CA77-44D9-A00C-290007E13EF9Q50439906-BDD7F254-775A-4E4E-B8C4-5ACA2A9539F0
P2860
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@ast
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@en
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@nl
type
label
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@ast
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@en
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@nl
prefLabel
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@ast
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@en
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@nl
P2860
P356
P1476
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo.
@en
P2093
Crispin R Dass
P2860
P304
P356
10.1211/0022357021778817
P577
2002-05-01T00:00:00Z